Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 6/20 | 0.47 |
| ▸ | ACE | P12821 | 2/20 | 0.47 |
| ▸ | CPA1 | P15085 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | ECE1 | P42892 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22342125 | 1.00 | MME (0.47) | MMEACECPA1ACE2ALDH1A1 | |
| SCHEMBL21030512 | 1.00 | MME (0.47) | MMEACECPA1ACE2ALDH1A1 | |
| SCHEMBL8805147 | 1.00 | MME (0.47) | MMEACECPA1ACE2ALDH1A1 | |
| SCHEMBL8927997 | 1.00 | MME (0.47) | MMEACECPA1ACE2ALDH1A1 | |
| SCHEMBL291483 | 1.00 | MME (0.47) | MMEACECPA1ACE2ALDH1A1 | |
| SCHEMBL330009 | 0.90 | — | — | |
| SCHEMBL330011 | 0.90 | — | — | |
| SCHEMBL330308 | 0.90 | — | — | |
| SCHEMBL13253551 | 0.88 | MME (0.40) | MMEACECPA1ACE2ALDH1A1 | |
| SCHEMBL31631405 | 0.88 | MME (0.40) | MMEACECPA1ACE2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220211796-A1 | PEPTIDE ANTIBIOTICS AND METHODS OF USE THEREOF | TRUSTEES OF TUFTS COLLEGE | 2022-07-07 | — | — | US | disclosed |
| EP-1996217-B1 | NOVEL ANTIBIOTIC COMPOSITIONS | CAMBRIDGE ENTPR LTD (GB) | 2010-11-10 | — | — | EP | disclosed |
| US-20100041613-A1 | NOVEL ANTIBIOTIC COMPOSITIONS | CAMBRIDGE ENTERPRISE LTD. (GB) | 2010-02-18 | — | — | US | disclosed |
| EP-1996217-A4 | NOVEL ANTIBIOTIC COMPOSITIONS | INFLAZYME PHARM LTD (CA) | 2009-08-12 | — | — | EP | disclosed |
| EP-1996217-A2 | NOVEL ANTIBIOTIC COMPOSITIONS | Inflazyme Pharmaceuticals, Ltd. (CA) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007103548-A2 | NOVEL ANTIBIOTIC COMPOSITIONS | INFLAZYME PHARMACEUTICALS LTD. (CA) | 2007-09-13 | — | — | WO | disclosed |
| WO-2007016556-A1 | MULTIFUNCTIONAL POLYMERS FOR PROMOTION OF OPSONIZATION OF TARGET CELLS AND ORGANISMS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041613-A1 | NOVEL ANTIBIOTIC COMPOSITIONS | MRPL21, NRDC, OTUB1 | MME 396/4885ACE 387/4885CPA1 2835/4885 |
| US-20220211796-A1 | PEPTIDE ANTIBIOTICS AND METHODS OF USE THEREOF | VIP, NGLY1, PEPD | MME 27/4885ACE 471/4885CPA1 879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.